April 13 (Reuters) - IDT Australia Ltd IDT.AX :
* FDA approval for temozolomide IDT.AX
* US distribution partner is already in place and commercial launch preparations are now underway
* Gained approval from the US food and drug administration (FDA) for its oral brain cancer drug Temozolomide
* Says IDT and mayne will immediately begin planning for a commercial US launch for the product
* Product now expected to deliver revenues in cy2016
* Source text for Eikon